Fresenius SE EBITDA 2016-2024 | FSNUY

Fresenius SE annual and quarterly EBITDA history from 2016 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Fresenius SE EBITDA for the quarter ending June 30, 2024 was $0.629B, a 54.18% decline year-over-year.
  • Fresenius SE EBITDA for the twelve months ending June 30, 2024 was $1.416B, a 77.26% decline year-over-year.
  • Fresenius SE 2023 annual EBITDA was $2.837B, a 57.22% decline from 2022.
  • Fresenius SE 2022 annual EBITDA was $6.631B, a 17.87% decline from 2021.
  • Fresenius SE 2021 annual EBITDA was $8.075B, a 0.44% decline from 2020.
Fresenius SE Annual EBITDA
(Millions of US $)
2023 $2,837
2022 $6,631
2021 $8,075
2020 $8,110
2019 $7,933
2018 $7,890
2017 $6,811
2016 $6,086
2015 $5,541
Fresenius SE Quarterly EBITDA
(Millions of US $)
2024-06-30 $629
2024-03-31 $923
2023-12-31 $82
2023-09-30 $-217
2023-06-30 $1,372
2023-03-31 $1,600
2022-12-31 $1,664
2022-09-30 $1,592
2022-06-30 $1,586
2022-03-31 $1,790
2021-12-31 $2,177
2021-09-30 $1,933
2021-06-30 $2,002
2021-03-31 $1,963
2020-12-31 $2,128
2020-09-30 $2,107
2020-06-30 $1,939
2020-03-31 $1,936
2019-12-31 $2,171
2019-09-30 $1,940
2019-06-30 $1,907
2019-03-31 $1,915
2018-12-31 $1,852
2018-09-30 $1,597
2018-06-30 $2,739
2018-03-31 $1,702
2017-12-31 $1,680
2017-09-30 $1,776
2017-06-30 $1,692
2017-03-31 $1,662
2016-12-31 $1,695
2016-09-30 $1,506
2016-06-30 $1,520
2016-03-31 $1,365
2015-12-31 $7,951
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $20.921B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.320B 17.55
DaVita (DVA) United States $12.060B 15.60
Encompass Health (EHC) United States $10.267B 24.21
Chemed (CHE) United States $8.277B 25.44
Elanco Animal Health (ELAN) United States $6.357B 14.29
RadNet (RDNT) United States $5.166B 122.54
Option Care Health (OPCH) United States $3.999B 18.95
Amedisys (AMED) United States $3.199B 22.78
Astrana Health (ASTH) United States $2.920B 41.31
LifeStance Health (LFST) United States $2.728B 0.00
Addus HomeCare (ADUS) United States $2.375B 27.86
U.S Physical Therapy (USPH) United States $1.464B 38.53
Pennant (PNTG) United States $1.004B 46.00
Aveanna Healthcare Holdings (AVAH) United States $0.929B 0.00
Atai Life Sciences (ATAI) Germany $0.198B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.013B 0.00
Ontrak (OTRK) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00